1,010
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia

, , , , , , , & show all
Pages 618-629 | Published online: 24 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Erika Vacchelli, Fernando Aranda, Florine Obrist, Alexander Eggermont, Jérôme Galon, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch. OncoImmunology 3:6.
Read now

Articles from other publishers (17)

Fei Fei, Mingfeng Zhang, Somayeh S. Tarighat, Eun Ji Joo, Lu Yang & Nora Heisterkamp. (2022) Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 23:22, pages 14359.
Crossref
Paola Fernanda Ruiz-Aparicio & Jean-Paul Vernot. (2022) Bone Marrow Aging and the Leukaemia-Induced Senescence of Mesenchymal Stem/Stromal Cells: Exploring Similarities. Journal of Personalized Medicine 12:5, pages 716.
Crossref
Paola Fernanda Ruiz-Aparicio, Gloria Inés Uribe, Adriana Linares-Ballesteros & Jean-Paul Vernot. (2021) Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity. Molecules 26:17, pages 5366.
Crossref
Toshihiro Tomii, Toshihiko Imamura, Kuniaki Tanaka, Itaru Kato, Azusa Mayumi, Emi Soma, Mio Yano, Kenichi Sakamoto, Takashi Mikami, Makiko Morita, Nobutaka Kiyokawa, Keizo Horibe, Souichi Adachi, Tatsutoshi Nakahata, Junko Takita & Hajime Hosoi. (2020) Leukemic cells expressing NCOR1-LYN are sensitive to dasatinib in vivo in a patient-derived xenograft mouse model. Leukemia 35:7, pages 2092-2096.
Crossref
Eun Ji Joo, Brian R Wasik, Colin Parrish, Helicia Paz, Martina Mϋhlenhoff, Hisham Abdel-Azim, John Groffen & Nora Heisterkamp. (2018) Pre-B acute lymphoblastic leukemia expresses cell surface nucleolin as a 9-O-acetylated sialoglycoprotein. Scientific Reports 8:1.
Crossref
Zhen Zhang, Lin Zhao, Xijin Wei, Qiang Guo, Xiaoxiao Zhu, Ran Wei, Xunqiang Yin, Yunhong Zhang, Bin Wang & Xia Li. (2018) Integrated bioinformatic analysis of microarray data reveals shared gene signature between MDS and AML. Oncology Letters.
Crossref
Yanhui Liu, Fei Xue, Yin Zhang, Pingchong Lei, Zhen Wang, Zunmin Zhu & Kai Sun. (2017) N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation. Anti-Cancer Drugs 28:10, pages 1097-1105.
Crossref
Elisabeth M.P. Steeghs, Isabel S. Jerchel, Willemieke de Goffau-Nobel, Alex Q. Hoogkamer, Judith M. Boer, Aurélie Boeree, Cesca van de Ven, Marco J. Koudijs, Nicolle J.M. Besselink, Hester A. de Groot-Kruseman, Christian Michel Zwaan, Martin A. Horstmann, Rob Pieters & Monique L. den Boer. (2017) JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia . Oncotarget 8:52, pages 89923-89938.
Crossref
Kamran Kaveh, Yutaka Takahashi, Michael A. Farrar, Guy Storme, Marcucci Guido, Jamie Piepenburg, Jackson Penning, Jasmine Foo, Kevin Z. Leder & Susanta K. Hui. (2017) Combination therapeutics of Nilotinib and radiation in acute lymphoblastic leukemia as an effective method against drug-resistance. PLOS Computational Biology 13:7, pages e1005482.
Crossref
Larissa Siqueira Penna, João Antonio Pêgas Henriques & Diego Bonatto. (2017) Anti-mitotic agents: Are they emerging molecules for cancer treatment?. Pharmacology & Therapeutics 173, pages 67-82.
Crossref
Fei Fei, Eun Ji Joo, Somayeh S. Tarighat, Isabelle Schiffer, Helicia Paz, Muller Fabbri, Hisham Abdel-Azim, John Groffen & Nora Heisterkamp. (2015) B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget 6:13, pages 11378-11394.
Crossref
Ashley S. Margol, Nathan J. Robison, Janahan Gnanachandran, Long T. Hung, Rebekah J. Kennedy, Marzieh Vali, Girish Dhall, Jonathan L. Finlay, Anat Erdreich-Epstein, Mark D. Krieger, Rachid Drissi, Maryam Fouladi, Floyd H. Gilles, Alexander R. Judkins, Richard Sposto & Shahab Asgharzadeh. (2015) Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas. Clinical Cancer Research 21:6, pages 1457-1465.
Crossref
Ke Yang & Li-wu Fu. (2015) Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review. Critical Reviews in Oncology/Hematology 93:3, pages 277-292.
Crossref
F Fei, H Abdel-Azim, M Lim, A Arutyunyan, M von Itzstein, J Groffen & N Heisterkamp. (2013) Galectin-3 in pre-B acute lymphoblastic leukemia. Leukemia 27:12, pages 2385-2388.
Crossref
O G Ottmann, R A Larson, H M Kantarjian, P D le Coutre, M Baccarani, A Hochhaus, D W Kim, X Fan, S Novick & F J Giles. (2012) Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia. Leukemia 27:6, pages 1411-1413.
Crossref
Reshmi Parameswaran, Min Lim, Anna Arutyunyan, Hisham Abdel-Azim, Christian Hurtz, Kam Lau, Markus Müschen, Robert K. Yu, Mark von Itzstein, Nora Heisterkamp & John Groffen. (2013) O -acetylated N -acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia . Journal of Experimental Medicine 210:4, pages 805-819.
Crossref
Ellen Weisberg, Qingsong Liu, Xin Zhang, Erik Nelson, Martin Sattler, Feiyang Liu, Maria Nicolais, Jianming Zhang, Constantine Mitsiades, Robert W. Smith, Richard Stone, Ilene Galinsky, Atsushi Nonami, James D. Griffin & Nathanael Gray. (2013) Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells. PLoS ONE 8:2, pages e56473.
Crossref